ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1883

Infections Are Associated With Increased Risk of Giant Cell Arteritis – a Population-Based Case-Control Study From Southern Sweden

Pavlos Stamatis1, Aleksandra Turkiewicz2, Martin Englund2, Goran Jönsson3, Jan-Åke Nilsson4, Carl Turesson5 and Aladdin Mohammad6, 1Clinical Sciences, Rheumatology Lund, Lund University, Lund, Sweden, 2Clinical Sciences Lund, Clinical Epidemiology Unit, Lund University, Lund, Sweden, 3Clinical Sciences Lund, Department of Infection Medicine, Lund University, Lund, Sweden, 4Department of Rheumatology, Skåne University Hospital, Malmö, Sweden, 5Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, 6Rheumatology, Department of Clinical Sciences, Lund, Lund University, Lund, Sweden

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Bacterial infections, giant cell arteritis, Infection, risk and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: 4M091 ACR Abstract: Vasculitis–Non-ANCA-Assocd & Rel D/Os I: Population-Based Studies(1881–1886)

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Previous studies have implicated infections as a risk factor for giant cell arteritis (GCA). The purpose of this study was to investigate the association between occurrence of infections and the development of GCA.

Methods: Patients diagnosed with biopsy-proven giant GCA between 2000 and 2016 were identified through the database of the Department of Pathology in Skåne, the southernmost region in Sweden. For each GCA case, 10 controls were randomly selected from the background population matched for age, sex, and area of residence. The index date for the controls was the same as the diagnosis date of their respective cases. We identified all infection events diagnosed before the date of GCA diagnosis (and before index date for controls) between 1998 and 2016, using the Skåne Healthcare Register based on International Classification of Diseases -10thversion (ICD-10) codes. First, we calculated the odds ratio (OR) of being exposed to an infection in GCA cases vs controls. Second, we evaluated the type of infection closest to the biopsy-proven GCA diagnosis (or index date). Conditional logistic regression models were used to calculate OR and 95% confidence intervals (CI).

Results: 1005 patients with biopsy-proven GCA (714 women, 71%) and 10 050 controls were included in this study. In total, 476 unique infection diagnoses were assigned for GCA cases prior to the biopsy-proven diagnosis as compared to 3722 unique infections for controls. Infections were more common among patients going to develop GCA vs. controls (47% vs. 37%) yielding the OR of 1.76 (95% CI 1.51–2.05). The median time from the latest diagnosed infection to GCA diagnosis was 0.9 years (interquartile range (IQR) 0.1 – 3.5), whereas the corresponding median time for the controls was 2.2 years (IQR 0.8-4.7). Acute upper respiratory tract infections, pneumonia, influenza and non-specific bacterial infections, but not skin or gastrointestinal infections, were associated with increased probability for later biopsy-proven GCA (Figure 1).

Conclusion: Infections, especially upper respiratory tracts infections, pneumonias and influenza were associated with later development of biopsy-proven GCA. Our findings corroborate previous reports of an association between GCA and infectious pathogens of the respiratory tract. The observed associations with unspecified infections may partly reflect diagnostic uncertainty in the early phase of GCA.

Figure 1. Odds ratios for developing GCA associated with prior exposure to infection


Disclosure: P. Stamatis, None; A. Turkiewicz, None; M. Englund, None; G. Jönsson, None; J. Å. Nilsson, None; C. Turesson, None; A. Mohammad, None.

To cite this abstract in AMA style:

Stamatis P, Turkiewicz A, Englund M, Jönsson G, Nilsson JÅ, Turesson C, Mohammad A. Infections Are Associated With Increased Risk of Giant Cell Arteritis – a Population-Based Case-Control Study From Southern Sweden [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/infections-are-associated-with-increased-risk-of-giant-cell-arteritis-a-population-based-case-control-study-from-southern-sweden/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/infections-are-associated-with-increased-risk-of-giant-cell-arteritis-a-population-based-case-control-study-from-southern-sweden/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology